Molnupiravir: New Covid drug cuts risk of death by 50 per cent, early trial results show
1 Mins read
Reading Time: < 1 minuteAn antiviral drug originally developed to treat influenza reduces hospitalisation and death from Covid-19 by 50 per cent in patients Read More
